INJECTION INDEXWeight management, clearly.
The online care edition
October 2026
Injection Index · Research library

The Review Index

37 provider and product profiles, with sources, offer breakdowns, and custom charts.

Read this firstArticle updated November 13, 2026; source dates below

Find a provider by name or care category, then use its offer data to compare the actual purchase.

Provider profiles
33

Programs and platforms with distinct service and billing models.

Medicine profiles
2

Wegovy and Zepbound explain product evidence, not clinic services.

Review total
35

The current editorial inventory; not a count of recommended treatments.

37 of 37 reviews

Compounded semaglutide

CoreAge Rx

A stated monthly compounded-medicine price, with important prescription and refund checkpoints.

$79/moRead the research →
Compounded semaglutide or tirzepatide

SuperHealthy Rx

A current-source review of SuperHealthy Rx GLP-1 care: a written plan that can be compared fairly, billing questions and evidence limits.

$85/mo semaglutide offerRead the research →
Compounded semaglutide or tirzepatide

Likeness Rx

Likeness Rx offers compounded semaglutide and tirzepatide with explicit term pricing. Its lowest advertised monthly equivalents are $79 and $129 on annual prepaid terms; month-to-month options cost more.

From $79/mo equivalentRead the research →
Plan-specific billing

Noom Med

A program with several treatment and billing tracks; identify your exact plan before comparing the headline.

Plan variesRead the research →
Introductory membership

Ro

Ro separates the cost of its care membership from the prescription cost.

$39 startRead the research →
Insurance, cash pay or compounded plan

Found

Found offers more than one treatment and payment pathway, so a personalized quote is essential.

Plan variesRead the research →
Membership only

Mochi Health

Mochi’s recurring membership and medicine charges need to be read together.

$79/moRead the research →
Compounded plans

RemedyMeds

A compounded-treatment program where the current quote matters more than a general promotional headline.

See quoteRead the research →
Offer may change

LevelsRx

A promotional starting price with different figures across the public offer; confirm the enrolled plan.

$88/moRead the research →
Treatment-specific

DirectMeds

DirectMeds needs a treatment-specific quote; the homepage does not support one universal injection price.

See quoteRead the research →
Plan-specific

MEDVi

A heavily marketed online offer that should be evaluated through the exact plan and clinical process.

See quoteRead the research →
Introductory membership

Hers

Hers combines a care membership with a separate medication cost; the introductory rate is not the whole bill.

$39 startRead the research →
Plan-specific

LifeMD

LifeMD’s full quote should connect the clinical program, medicine, and any additional expenses.

See quoteRead the research →
Term-based membership

WeightWatchers Clinic

A familiar behavior-support platform with a separate clinical membership and prescription expense.

Dated $25Read the research →
Compounded options

WellMedr

Formulation details deserve special attention when an offer combines a GLP-1 ingredient with added substances.

See quoteRead the research →
Plan-specific

Eden

Eden has several treatment offers; distinguish the introductory promotion from the actual renewal.

See quoteRead the research →
Care membership

Ivím Health

Ivím’s advertised membership should be paired with the treatment quote before assessing the total cost.

$75/moRead the research →
Treatment-specific plan

Henry

Henry describes bundled provider visits, medication and supplies; monthly flexibility needs to be distinguished from the balance on a longer plan.

See quoteRead the research →
Treatment-specific

TrimRx

TrimRx advertises starting offers, but its official pages do not consistently tie the lowest figure to one medicine format.

$179 startRead the research →
Treatment-specific

Gala Health

Gala describes clinician review and continuing support; its displayed outcome graph models underlying trial evidence rather than Gala patient results.

See quoteRead the research →
Offer-specific

AltRx

AltRx’s low starting GLP-1 rate sits alongside different compounded and branded offers; paid testimonials and complete plan terms need their own reading.

$89/moRead the research →
Consultation only

PlushCare

PlushCare’s $129 self-pay initial visit is a consultation price; membership, medicines and laboratory costs are separate parts of the comparison.

$129 visitRead the research →
Plan-specific

FuturHealth

FuturHealth combines a platform, nutrition features and access to medical professionals; its program comparison and complete current quote need careful qualification.

See quoteRead the research →
Treatment-specific

ReflexMD

ReflexMD describes separate physician and wellness-advisor roles, with medication conditional on review; price and continuing subscription terms remain unresolved.

See quoteRead the research →
Plan-specific

G-Plans

G-Plans combines clinical access and nutrition tools; its weight-loss illustration refers to branded trials rather than a measured G-Plans cohort.

See quoteRead the research →
Plan-specific

Fridays

Fridays’ buy-three-get-one promotion is a discounted four-month membership bill, not a separate free shipment; medication and renewal details need their own scope.

See quoteRead the research →
Treatment-specific

Shed

Shed advertises compounded semaglutide from $159 and a conditional 120-day guarantee; its wider wellness catalogue and outcome headlines are separate records.

$159/moRead the research →
Treatment-specific

Brightmeds

Brightmeds describes an all-in-one offer but separates its platform from medical and pharmacy care; the exact quote and dispensing preparation remain important.

See quoteRead the research →
Introductory offer

Enhance.MD

Enhance.MD’s introductory offer needs its continuing charge and supply period; combined-drug marketing is not approval or superiority evidence.

$112 startRead the research →
Offer-specific

SnagRx

SnagRx advertises low flat monthly prices, but longer subscription terms and its medically limited refund rule qualify the cancellation headline.

$69/moRead the research →
Treatment-specific

BetterMe Rx

BetterMe Rx separates its telehealth platform from prescribing and pharmacy dispensing; the first-order discount does not reveal the complete continuing price.

See quoteRead the research →
Branded medicine

Wegovy

Wegovy is a branded semaglutide medicine record, not a clinic; its current forms, indications and savings terms must remain distinct from a provider’s package.

Offer variesRead the research →
Branded medicine

Zepbound

Zepbound’s manufacturer record identifies tirzepatide, weight-management and specific sleep-apnea uses; savings routes and care access are separate from the medicine itself.

Offer variesRead the research →
Compounded plan

Trimi

Trimi explicitly separates an annual monthly equivalent from the upfront bill: semaglutide is advertised at $1,188 for twelve months, with a different month-to-month rate.

$99/mo equiv.Read the research →
Compounded plan

Embody

Embody advertises low starting prices and no membership fee, while its FAQ ties the actual rate to the selected plan length and defines cancellation around shipment processing.

$69/moRead the research →
Compounded injection program

CareBox

CareBox’s product headlines need a selected-plan invoice; its refund policy distinguishes early cancellation, clinical disqualification and unshipped prepaid months.

Advertised starts: $69 semaglutide / $119 tirzepatideRead the research →
Prepaid compounded injection plans

He & She MD

He & She MD publishes three-, six- and twelve-month totals, but its linked membership terms do not clearly resolve the cancellation treatment of those specific packages.

Semaglutide $447 / 3 months, $834 / 6 months or $1,188 annuallyRead the research →
The details, visualized

A directory with different kinds of entries

A guide to this publication and the records behind a decision

  1. Provider profiles33

    Programs and platforms with distinct service and billing models.

  2. Medicine profiles2

    Wegovy and Zepbound explain product evidence, not clinic services.

  3. Review total35

    The current editorial inventory; not a count of recommended treatments.

Use the source documents and your selected agreement. A public description does not determine personal treatment eligibility.

View the printable chart imageA directory with different kinds of entries. The same values and context are available in the data table above.
Research note 01

How to use the filters

The review search matches names, care descriptions and summaries. The category filter narrows the directory without turning it into a clinical recommendation. A provider can appear in more than one category because its catalogue may include several treatment paths.

Open the research summary to identify the most useful unanswered question, then follow the chart’s sources. The prices on the directory cards are starting points with different scopes. Use the full review to distinguish membership, medicine, promotion and commitment.

Before you decide

Questions worth answering

Where can I report a problem with this page?

Use the contact page and include the affected URL and a public source or a description of the website problem. Do not send sensitive medical or payment records to the editorial inbox.

Evidence behind this page

Sources & chart notes

Source dates are listed with each document. Earlier research and later offer updates are identified separately. Provider pages establish advertised terms. Labels and trial reports describe specific medicines and study populations. Medical review has not been completed.